In vitro studies using platelet-rich plasma: Minimum reporting requirements. | Cell Biol Int;44(12): 2380-2382, 2020 12. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL CLAP/WR-PAHO/WHO

Latin-American Center for Perinatology, Woman and Reproductive Health

Subject descriptor lookup Advanced Search

In vitro studies using platelet-rich plasma: Minimum reporting requirements.

Sharun, Khan; Pawde, Abhijit M.

Affiliation

Sharun K; Division of Surgery, ICAR-Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, India.
Pawde AM; Division of Surgery, ICAR-Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, India.

Cell Biol Int ; 44(12): 2380-2382, 2020 12.

Article in En | MEDLINE | ID: mdl-32902883

Subject(s)

Integrin beta1; Platelet-Rich Plasma; Actin Cytoskeleton; Apoptosis; Gingipain Cysteine Endopeptidases; Osteoblasts

Key words

classification; coding; in vitro; osteogenesis; platelet-rich plasma

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Integrin beta1 / Platelet-Rich Plasma Language: En Journal: Cell Biol Int Year: 2020 Type: Article Affiliation country: India

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Integrin beta1 / Platelet-Rich Plasma Language: En Journal: Cell Biol Int Year: 2020 Type: Article Affiliation country: India